LSP has raised €1bn for the biggest European life sciences venture capital fund ever raised, which was boosted by the firm picking up investment from buyout giant EQT three months ago. The post EQT buyout
Buyout giant EQT has agreed to buy into €2.2bn-managing European life science venture capital firm LSP for €450m to strengthen its position in the healthcare sector. A potential earn-out payment of €25m will also be
European life science investor LSP has launched a dedicated fund targeting the fight against neurodegenerative diseases. The LSP Dementia Fund will be managed by Professor Philip Scheltens, a world-renowned dementia scientist and thought leader, the firm
European life science and healthcare investor LSP has led a €32m Series B financing round for VarmX, a biotech company focused on developing approaches for the reversal of anticoagulation.
